Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • GTPase
    (2)
  • COX
    (1)
  • HIV Protease
    (1)
  • Nucleoside Antimetabolite/Analog
    (1)
  • PKM
    (1)
  • Parasite
    (1)
  • Phospholipase
    (1)
  • Potassium Channel
    (1)
  • Ras
    (1)
  • Others
    (10)
Filter
Search Result
Results for "

RBC

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    12
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    2
    TargetMol | Natural_Products
  • Recombinant Protein
    7
    TargetMol | Recombinant_Protein
  • 1
    TargetMol | Inhibitors_Agonists
Mitapivat
PKR-IN-1
T42231260075-17-9
Mitapivat (PKR-IN-1), also known as PKM2 activator 1020 is a PKM2 activator (pyruvate kinase activator) for the treatment of pyruvate kinase deficiency.
  • Inquiry Price
Size
QTY
Globotetraosylceramides (porcine RBC)
T3804811034-93-8
Globotetraosylceramides are bioactive neutral glycosphingolipids. They are the major glycolipids in human erythrocytes. They act as receptors for the Shiga toxins Stx1, Stx2, and Stx2e, the cytotoxic protein pierisin-1, and parvovirus B19. Globotetraosylceramides increase the expression of proteins responsible for enamel deposition, including ameloblastin, amelogenin, and enamelin, in dental epithelial cells and activate the ERK and p38 MAPK signaling pathways. Levels of globotetraosylceramides are elevated in fibroblasts from patients with salt and pepper syndrome, a neurocutaneous condition characterized by intellectual disability and hyper- and hypo-pigmented skin. Globotetraosylceramides (porcine RBC) contains a mixture of globotetraosylceramides with variable fatty acyl chain lengths isolated from porcine red blood cells.
  • Inquiry Price
Size
QTY
Lactosylceramide (porcine RBC)
TXB-00387
Lactosylceramide (LacCer) (porcine RBC) is an endogenous bioactive sphingolipid that plays a crucial role in mediating innate immune functions.
  • Inquiry Price
Inquiry
Size
QTY
RBC8
T6634361185-42-4
RBC8 is a specific GTPases RalA RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
RBC10
RBC 10, RBC-10
T24706362503-73-9
RBC10 inhibits the binding of Ral to its effector RALBP1, as well as inhibiting Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines.
  • Inquiry Price
6-8 weeks
Size
QTY
RBC6
RBC-6,RBC 6
T24707381186-64-7
RBC6 is an inhibitor of the binding of Ral to its effector RALBP1.
  • Inquiry Price
6-8 weeks
Size
QTY
Peldesine
BCX 34
T12399133432-71-0In house
Peldesine (BCX 34) is an effective, competitive, reversible, and orally active inhibitor of purine nucleoside phosphorylase. Peldesine inhibits T-cell proliferation with an IC50 of 800 nM. Peldesine can be used in research on cutaneous T-cell lymphoma, psoriasis and HIV infection.
  • Inquiry Price
6-8 weeks
Size
QTY
Digitonin
T272111024-24-1
Digitonin is a natural product of the glycoside family and is a detergent. Digitonin has antitumor activity, binds to cholesterol molecules to increase the permeability of cell membranes, and is active in the cleavage of cell membranes in a wide range of cells.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
Senicapoc
ICA-17043
T3528289656-45-7
Senicapoc (ICA-17043) is a potent inhibitor of the Gardos channel that ameliorates RBC dehydration in the SAD mouse. It blocks Ca2+-induced rubidium flux from human RBCs with an IC50 value of 11 ± 2 nM (CLT IC50 = 100 ± 12 nM) and inhibits RBC dehydration with an IC50 of 30 ± 20 nM. Senicapoc is used in the treatment of Sickle Cell Disease and Sickle Cell Anemia.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
Columbin
T4S0590546-97-4
1. Columbin has anti-inflammatory activity. 2. Columbin has chemopreventive ability against human colon cancer. 3. Columbin inhibits PLA2 hydrolysis of ghost RBC in a dose-dependent fashion.
  • Inquiry Price
Size
QTY
Peldesine dihydrochloride
T607992772702-10-8
Peldesine (BCX 34) dihydrochloride is a potent, competitive, reversible, and orally active inhibitor of purine nucleoside phosphorylase (PNP), with IC50 values of 36 nM, 5 nM, and 32 nM against human, rat, and mouse red blood cell (RBC) PNP, respectively. Additionally, it inhibits T-cell proliferation with an IC50 of 800 nM, showing promise for research into cutaneous T-cell lymphoma, psoriasis, and HIV infection [1] [2] [3] [4].
  • Inquiry Price
1-2 weeks
Size
QTY
Ligufalimab
T770652428381-55-7
Ligufalimab (AK 117), a humanized IgG4 monoclonal antibody targeting CD47, does not lead to red blood cell (RBC) hemagglutination but promotes phagocytosis and exhibits anti-tumor activity [1].
  • Inquiry Price
2-4 weeks
Size
QTY